| Serial Number | 97357965 |
| Word Mark | ELORIUM |
| Filing Date | Monday, April 11, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Friday, February 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 29, 2023 |
| Goods and Services | Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of a behavioral stressor; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 18, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037 |
| Party Name | Vanda Pharmaceuticals Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Washington, DC 20037 |
| Event Date | Event Description |
| Tuesday, February 6, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 2, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, February 2, 2024 | SOU EXTENSION 1 FILED |
| Friday, February 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, October 24, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 29, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 29, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 9, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 19, 2023 | ASSIGNED TO EXAMINER |
| Thursday, May 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 4, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 8, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 8, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 8, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, January 23, 2023 | ASSIGNED TO EXAMINER |
| Monday, April 18, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 14, 2022 | NEW APPLICATION ENTERED |